BioMimetic Therapeutics Files For $50 Million IPO
Published: Feb 10, 2006
FRANKLIN, Tenn.--(BUSINESS WIRE)--Feb. 10, 2006--BioMimetic Therapeutics, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the proposed initial public offering of primary shares of its common stock. Deutsche Bank Securities Inc. will be acting as the sole book-running manager. Pacific Growth Equities, LLC, will be acting as the co-lead manager and First Albany Capital, Inc. and AG Edwards & Sons, Inc. will be co-managers. The offering will be made only by means of the prospectus. When available, copies of the preliminary prospectus relating to this offering may be obtained from Deutsche Bank Securities Inc. at 60 Wall Street, New York, New York 10005, (212) 250-2500.